1. Miroshnichenko II. Ratsional’noe dozirovanie lekarstvennykh sredstv. Prakticheskoe rukovodstvo. M.: Izdatel’stvo «Meditsinskoe informatsionnoe agenstvo»; 2011. (In Russ.)
2. Peng S, Li W, Lv L, Zhang Z, Zhan X. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression. Discovery Medicine. 2018;26(143):127-136. https://www.discoverymedicine.com/Shiyong-Peng/2018/10/bdnf-as-biomarker-in-diagnosis-and-treatment-for-schizophrenia-and-depression
3. Bezrukov MV, Shilov IuE, Shestakova NV, Kliushnik TP. The biological evaluation of depression severity: a novel method for the determination of platelet serotonin concentration. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(8):51-57. https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2014/8/031997-7298201488/annotation
4. N-acetylaspartate is a biomarker of psychiatric and neurological disorders
5. Yakovleva OB, Safarova TP, Miroshnichenko II, Platova AI. Gomotsistein pri depressii pozdnego vozrasta. Psikhiatriya. 2015;66(2):29-36. (In Russ.). https://www.journalpsychiatry.com/jour/article/view/28?locale=ru_RU